Latest news
Eli Lilly (NYSE: LLY) Files For Next-Gen Weight-Loss Drug Retatrutide In Q1 2027, Leaving Novo Nordisk (NYSE: NVO) Scrambling - foreignpolicyjournal.comforeignpolicyjournal.com · Mon, 10 Aug 2026 00:24:00 GMTHow weight-loss medication is changing relationships with alcohol - BBCBBC · Sat, 08 Aug 2026 23:30:06 GMTMemorial doctor discusses benefits, risks of GLP-1 weight loss medications - WLOXWLOX · Sat, 08 Aug 2026 13:44:00 GMTEli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem - The Motley FoolThe Motley Fool · Fri, 07 Aug 2026 23:30:00 GMTDon’t Curtail Access to Weight-Loss Drugs - Progressive.orgProgressive.org · Fri, 07 Aug 2026 19:52:41 GMTOral Weight Loss Pill Helps Patients Lose up to 12% of Body Weight - SciTechDailySciTechDaily · Fri, 07 Aug 2026 18:12:52 GMTBank of America spends $250M yearly on GLP-1s for workers, CEO says - USA TodayUSA Today · Fri, 07 Aug 2026 17:44:00 GMTWeight-loss medications: which are the most effective? - British Heart FoundationBritish Heart Foundation · Fri, 07 Aug 2026 15:59:12 GMT